Hormonal control of ketogenesis. Biochemical considerations

J. D. McGarry, D. W. Foster

Research output: Contribution to journalArticle

95 Citations (Scopus)

Abstract

A two-site, bihormonal concept for the control of ketone body production is proposed. Thus, ketosis is viewed as the result of increased mobilization of free fatty acids from adipose tissue (site 1) to the liver (site 2), coupled with simultaneous enhancement of the liver's capacity to convert these substrates into acetoacetic and β-hydroxybutyric acids. The former event is believed to be triggered by a fall in plasma insulin levels while the latter is considered to be effected primarily by the concomitant glucagon excess characteristic of the ketonic state. Although the precise mechanism whereby elevation of the circulating [glucagon]:[insulin] ratio stimulates hepatic ketogenic potential is not known, activation of the carnitine acyltransferase reaction, the first step in the oxidation of fatty acids, is an essential feature. Two prerequisites for this metabolic adaptation in liver appear to be an elevation in its carnitine content and depletion of its glycogen stores. Despite present limitations the model (evolved mainly from rat studies) provides a framework for the description of various types of clinical ketosis in biochemical terms and may be useful for future studies.

Original languageEnglish (US)
Pages (from-to)495-501
Number of pages7
JournalArchives of Internal Medicine
Volume137
Issue number4
DOIs
StatePublished - 1977

Fingerprint

Ketosis
Liver
Glucagon
Carnitine Acyltransferases
Insulin
Hydroxybutyrates
Ketone Bodies
Essential Fatty Acids
Carnitine
Glycogen
Nonesterified Fatty Acids
Adipose Tissue
acetoacetic acid

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Hormonal control of ketogenesis. Biochemical considerations. / McGarry, J. D.; Foster, D. W.

In: Archives of Internal Medicine, Vol. 137, No. 4, 1977, p. 495-501.

Research output: Contribution to journalArticle

@article{8264692d3b5a437685b4e69bef5f87cd,
title = "Hormonal control of ketogenesis. Biochemical considerations",
abstract = "A two-site, bihormonal concept for the control of ketone body production is proposed. Thus, ketosis is viewed as the result of increased mobilization of free fatty acids from adipose tissue (site 1) to the liver (site 2), coupled with simultaneous enhancement of the liver's capacity to convert these substrates into acetoacetic and β-hydroxybutyric acids. The former event is believed to be triggered by a fall in plasma insulin levels while the latter is considered to be effected primarily by the concomitant glucagon excess characteristic of the ketonic state. Although the precise mechanism whereby elevation of the circulating [glucagon]:[insulin] ratio stimulates hepatic ketogenic potential is not known, activation of the carnitine acyltransferase reaction, the first step in the oxidation of fatty acids, is an essential feature. Two prerequisites for this metabolic adaptation in liver appear to be an elevation in its carnitine content and depletion of its glycogen stores. Despite present limitations the model (evolved mainly from rat studies) provides a framework for the description of various types of clinical ketosis in biochemical terms and may be useful for future studies.",
author = "McGarry, {J. D.} and Foster, {D. W.}",
year = "1977",
doi = "10.1001/archinte.137.4.495",
language = "English (US)",
volume = "137",
pages = "495--501",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "4",

}

TY - JOUR

T1 - Hormonal control of ketogenesis. Biochemical considerations

AU - McGarry, J. D.

AU - Foster, D. W.

PY - 1977

Y1 - 1977

N2 - A two-site, bihormonal concept for the control of ketone body production is proposed. Thus, ketosis is viewed as the result of increased mobilization of free fatty acids from adipose tissue (site 1) to the liver (site 2), coupled with simultaneous enhancement of the liver's capacity to convert these substrates into acetoacetic and β-hydroxybutyric acids. The former event is believed to be triggered by a fall in plasma insulin levels while the latter is considered to be effected primarily by the concomitant glucagon excess characteristic of the ketonic state. Although the precise mechanism whereby elevation of the circulating [glucagon]:[insulin] ratio stimulates hepatic ketogenic potential is not known, activation of the carnitine acyltransferase reaction, the first step in the oxidation of fatty acids, is an essential feature. Two prerequisites for this metabolic adaptation in liver appear to be an elevation in its carnitine content and depletion of its glycogen stores. Despite present limitations the model (evolved mainly from rat studies) provides a framework for the description of various types of clinical ketosis in biochemical terms and may be useful for future studies.

AB - A two-site, bihormonal concept for the control of ketone body production is proposed. Thus, ketosis is viewed as the result of increased mobilization of free fatty acids from adipose tissue (site 1) to the liver (site 2), coupled with simultaneous enhancement of the liver's capacity to convert these substrates into acetoacetic and β-hydroxybutyric acids. The former event is believed to be triggered by a fall in plasma insulin levels while the latter is considered to be effected primarily by the concomitant glucagon excess characteristic of the ketonic state. Although the precise mechanism whereby elevation of the circulating [glucagon]:[insulin] ratio stimulates hepatic ketogenic potential is not known, activation of the carnitine acyltransferase reaction, the first step in the oxidation of fatty acids, is an essential feature. Two prerequisites for this metabolic adaptation in liver appear to be an elevation in its carnitine content and depletion of its glycogen stores. Despite present limitations the model (evolved mainly from rat studies) provides a framework for the description of various types of clinical ketosis in biochemical terms and may be useful for future studies.

UR - http://www.scopus.com/inward/record.url?scp=0017566802&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017566802&partnerID=8YFLogxK

U2 - 10.1001/archinte.137.4.495

DO - 10.1001/archinte.137.4.495

M3 - Article

VL - 137

SP - 495

EP - 501

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 4

ER -